WallStSmart

Medtronic PLC (MDT)vsNeuronetics Inc (STIM)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Medtronic PLC generates 23690% more annual revenue ($35.48B vs $149.16M). MDT leads profitability with a 13.0% profit margin vs -26.2%. MDT earns a higher WallStSmart Score of 56/100 (C).

MDT

Buy

56

out of 100

Grade: C

Growth: 4.0Profit: 6.5Value: 7.3Quality: 5.0

STIM

Hold

38

out of 100

Grade: F

Growth: 8.0Profit: 2.0Value: 5.0Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

MDTSignificantly Overvalued (-255.7%)

Margin of Safety

-255.7%

Fair Value

$24.34

Current Price

$86.58

$62.24 premium

UndervaluedFair: $24.34Overvalued

Intrinsic value data unavailable for STIM.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

MDT4 strengths · Avg: 8.3/10
Market CapQuality
$110.62B9/10

Large-cap with strong market position

Price/BookValuation
2.3x8/10

Reasonable price relative to book value

Operating MarginProfitability
20.0%8/10

Strong operational efficiency at 20.0%

Free Cash FlowQuality
$2.30B8/10

Generating 2.3B in free cash flow

STIM1 strengths · Avg: 10.0/10
Revenue GrowthGrowth
85.7%10/10

Revenue surging 85.7% year-over-year

Areas to Watch

MDT1 concerns · Avg: 2.0/10
EPS GrowthGrowth
-11.8%2/10

Earnings declined 11.8%

STIM4 concerns · Avg: 2.5/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$100.45M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-134.9%2/10

ROE of -134.9% — below average capital efficiency

Profit MarginProfitability
-26.2%1/10

Currently unprofitable

Comparative Analysis Report

WallStSmart Research

Bull Case : MDT

The strongest argument for MDT centers on Market Cap, Price/Book, Operating Margin.

Bull Case : STIM

The strongest argument for STIM centers on Revenue Growth. Revenue growth of 85.7% demonstrates continued momentum.

Bear Case : MDT

The primary concerns for MDT are EPS Growth.

Bear Case : STIM

The primary concerns for STIM are EPS Growth, Market Cap, Return on Equity.

Key Dynamics to Monitor

MDT profiles as a value stock while STIM is a hypergrowth play — different risk/reward profiles.

STIM carries more volatility with a beta of 0.94 — expect wider price swings.

STIM is growing revenue faster at 85.7% — sustainability is the question.

MDT generates stronger free cash flow (2.3B), providing more financial flexibility.

Bottom Line

MDT scores higher overall (56/100 vs 38/100). Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Medtronic PLC

HEALTHCARE · MEDICAL DEVICES · USA

Medtronic plc is an American-Irish registered medical device company that primarily operates in the United States. Medtronic has an operational and executive headquarters in Fridley, Minnesota in the US.

Neuronetics Inc

HEALTHCARE · MEDICAL DEVICES · USA

Neuronetics, Inc., a commercial-stage medical technology company, designs, develops, and markets products for patients with psychiatric disorders in the United States and internationally. The company is headquartered in Malvern, Pennsylvania.

Want to dig deeper into these stocks?